Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease
Updated: Sep 5, 2022
Gisli Jenkins, Professor of Experimental Medicine and NIHR Professor from the Faculty of Medicine & Health Sciences at the University of Nottingham and NIHR Nottingham Biomedical Research Centre has just had the results of an International study "Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease: An International Multicenter Study" accepted for publication in the American Journal of Respiratory and Critical Care Medicine.
The research involved 37 hospitals and many more clinicians from around the UK and Europe conducting an audit of their hospital admissions, which found 349 patients with a prior diagnosis of ILD admitted to hospital with #COVID-19 between 1 March and 1 May 2020 and compared this data with patients, without ILD obtained from the ISARIC 4C cohort, admitted with COVID-19 over the same period.
The primary outcome was survival. Secondary analysis distinguished IPF from non-IPF ILD and used lung function to determine the greatest risks of death.
The audit, results and this publication were the product of a monumental team effort.